Portfolio Design Labs’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$649K Buy
2,916
+11
+0.4% +$2.56K 0.1% 143
2026
Q2
$690K Buy
2,905
+9
+0.3% +$1.87K 0.11% 142
2026
Q1
$612K Buy
2,896
+1,433
+98% +$309K 0.11% 156
2025
Q4
$301K Buy
1,463
+18
+1% +$3.39K 0.05% 170
2025
Q3
$227K Sell
1,445
-1,143
-44% -$177K 0.04% 187
2025
Q2
$435K Buy
+2,588
New +$384K 0.09% 108

Other funds holding CAH

Portfolio Design Labs's CAH Position: Q3 2026 in Review

Portfolio Design Labs increased its Cardinal Health (CAH) stake by 0.38% in Q3 2026, buying an estimated $2.56K and bringing the position to 2,916 shares worth $649K. The position accounts for 0.1% of the portfolio, ranked #143.

Portfolio Design Labs first reported a position in CAH in Q2 2025 and has held it in 6 quarters since. The position peaked at $690K in Q2 2026. 1,497 funds tracked by Wall St. Rank hold CAH as of Q3 2026.

  • Portfolio Design Labs held 2,916 shares of Cardinal Health worth $649K as of Q3 2026.
  • Portfolio Design Labs bought 11 Cardinal Health shares in Q3 2026, an estimated $2.56K.
  • Cardinal Health made up 0.1% of Portfolio Design Labs's portfolio in Q3 2026, its #143 holding.
  • Portfolio Design Labs first reported a position in Cardinal Health in Q2 2025 and has held it in 6 quarters since.
  • Portfolio Design Labs's Cardinal Health position peaked at $690K in Q2 2026.
  • 1,497 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2026.

Based on Portfolio Design Labs's 13F filing for Q3 2026, filed 4 Nov 2026.